Drug Channels Archive for October, 2023

Click a link below to view the mailing archive as if it had been sent to you.

2023-10-31 07:47		Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup
2023-10-30 07:47		Drug Channels - thINc's Value-Based Care Summit
2023-10-27 07:45		Drug Channels - GoodRx Announces New Way for Consumers To Access Sanofi's Lantus for $35 at Over 70,000 Pharmacies Nationwide
2023-10-24 07:52		Drug Channels - Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market
2023-10-23 07:54		Drug Channels - Informa Connect's Trade and Channel Strategies
2023-10-20 07:47		Drug Channels - How Centralized Prescription Fulfillment Allows Pharmacists to Better Help Patients
2023-10-17 07:47		Drug Channels - The Battle for Oncology Margin: How Private Equity Enables Vertical Integration by Pharmaceutical Wholesalers
2023-10-16 07:47		Drug Channels - Informa Connect's PBM Contracting Summit
2023-10-13 07:47		Drug Channels - Copay Adjustment Programs: What Brand and Hub Teams Need to Know
2023-10-10 07:42		Drug Channels - NOW AVAILABLE: The 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
2023-10-06 07:48		Drug Channels - Four Ways Digital Intake Can Transform Patient Support Programs, Overcome Access Barriers, and Improve Outcomes
2023-10-05 07:47		Drug Channels - The Economics of Copay Accumulators, Maximizers, and Alternative Funding Programs (Video) (rerun)
2023-10-04 07:43		Drug Channels - Gross-to-Net Bubble Update: 2022 Pricing Realities at 10 Top Drugmakers (rerun)
2023-10-03 07:54		Drug Channels - Four Crucial Questions about the Humira Biosimilar Price War (rerun)
2023-10-02 07:47		Drug Channels - Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations (rerun)

<< Archive Index • Subscribe >>